| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.032 | 0.8 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.034 | 0.8 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.9 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.9 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |